Dr. Dan Stickler

I think a lot of it is that we just don't have the available testing that can measure the responses that you get from it. I mean, just... A lot of stuff with like yoga and meditation. I mean, for years, everybody knew it worked. But how do you quantify that? And then comes along epigenetics.

And then we have scientific evidence that says, oh, okay, yes, we do have the scientific evidence that it works. And I think a lot of the modalities that we look into are the ones that are the meditation of 20 years ago prior to that. So we'll do a lot of work with that. We work with a lot of IRBs, so Institutional Review Board studies that are early access to IRBs.

And then we have scientific evidence that says, oh, okay, yes, we do have the scientific evidence that it works. And I think a lot of the modalities that we look into are the ones that are the meditation of 20 years ago prior to that. So we'll do a lot of work with that. We work with a lot of IRBs, so Institutional Review Board studies that are early access to IRBs.

And then we have scientific evidence that says, oh, okay, yes, we do have the scientific evidence that it works. And I think a lot of the modalities that we look into are the ones that are the meditation of 20 years ago prior to that. So we'll do a lot of work with that. We work with a lot of IRBs, so Institutional Review Board studies that are early access to IRBs.

Different forms of testing, different forms of intervention that we feel might be promising for moving forward. And so we'd like to really stay on that leading edge of the new and exciting therapies that are out there.

Different forms of testing, different forms of intervention that we feel might be promising for moving forward. And so we'd like to really stay on that leading edge of the new and exciting therapies that are out there.

Different forms of testing, different forms of intervention that we feel might be promising for moving forward. And so we'd like to really stay on that leading edge of the new and exciting therapies that are out there.

Like we've been doing a lot of apheresis, which is the removal of a liter of plasma.

Like we've been doing a lot of apheresis, which is the removal of a liter of plasma.

Like we've been doing a lot of apheresis, which is the removal of a liter of plasma.

Yeah, I mean, the plasma is carrying a bunch of proteins, exosomes, microRNAs, but they can also be carrying a lot of inflammatory things. This is like the email system of the body. So it's sending out all of these messages to inform other cells of what is happening in the environment. And basically, we live in a fairly toxic environment.

Yeah, I mean, the plasma is carrying a bunch of proteins, exosomes, microRNAs, but they can also be carrying a lot of inflammatory things. This is like the email system of the body. So it's sending out all of these messages to inform other cells of what is happening in the environment. And basically, we live in a fairly toxic environment.

Yeah, I mean, the plasma is carrying a bunch of proteins, exosomes, microRNAs, but they can also be carrying a lot of inflammatory things. This is like the email system of the body. So it's sending out all of these messages to inform other cells of what is happening in the environment. And basically, we live in a fairly toxic environment.

So it made a lot of stress responses in there. Session of apheresis removes about 40% of that plasma volume. And then we replace it with saline and albumin. And so that albumin has a bunch of clean binding sites on it to bind up toxins and other things. Items in the blood. And so it cleanses the blood essentially. We're involved in a study that's looking at it with aging.

So it made a lot of stress responses in there. Session of apheresis removes about 40% of that plasma volume. And then we replace it with saline and albumin. And so that albumin has a bunch of clean binding sites on it to bind up toxins and other things. Items in the blood. And so it cleanses the blood essentially. We're involved in a study that's looking at it with aging.

So it made a lot of stress responses in there. Session of apheresis removes about 40% of that plasma volume. And then we replace it with saline and albumin. And so that albumin has a bunch of clean binding sites on it to bind up toxins and other things. Items in the blood. And so it cleanses the blood essentially. We're involved in a study that's looking at it with aging.

We're working with some stuff with people that have Lyme, people that have long COVID. And we're seeing anecdotally really good responses from it. We can't say anything from a scientific standpoint quite yet because we don't have enough people involved to do that, but that's what part of this study is determining.

We're working with some stuff with people that have Lyme, people that have long COVID. And we're seeing anecdotally really good responses from it. We can't say anything from a scientific standpoint quite yet because we don't have enough people involved to do that, but that's what part of this study is determining.

We're working with some stuff with people that have Lyme, people that have long COVID. And we're seeing anecdotally really good responses from it. We can't say anything from a scientific standpoint quite yet because we don't have enough people involved to do that, but that's what part of this study is determining.

There have been some studies out of Stanford that showed positive effects on aging, cognitive decline in older people, but in some of the younger people we're also seeing, especially with long COVID, we're seeing really impressive results. That's one area we're also involved in a study that's using young plasma to replace the plasma that we remove.